Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical Trial

Cardiovascular Risk and Diseases

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

JAMA Cardiol

Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group

doi: 10.1001/jamacardio.2026.0245

Heart FailureFurther Publications

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

JAMA Cardiol

Lu H, Kosztin A, Claggett BL, Foà A, Pabón MA, Desai AS, Jhund PS, Henderson AD, Merkely B, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B, Amarante F, Saarinen R, De Sanctis Y, Glasauer A, McMurray JJV, Vaduganathan M, Solomon SD

doi: 10.1001/jamacardio.2026.0682

Cardiovascular Risk and Diseases

Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial

JAMA Cardiol

Nissen SE, Wolski K, D'Alessio D, Weerakkody G, Kiljanski J, Wiese RJ, Pavo I, Cariou B, Nicholls SJ

doi: 10.1001/jamacardio.2026.0767

Atrial FibrillationHeart, Artery and Coronary Diseases

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

JAMA Cardiol

Yamaguchi J, Arashi H, Hagiwara N, Yasuda S, Kaikita K, Akao M, Ako J, Matoba T, Nakamura M, Miyauchi K, Matsui K, Ogawa H, AFIRE Investigators

doi: 10.1001/jamacardio.2025.2611

Further Publications

Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials

JAMA Cardiol

Lo KB, Ostrominski JW, Hamatani Y, Claggett BL, Agarwal R, Anker SD, Filippatos G, Rossing P, Ruilope LM, Pitt B, Briasoulis A, Stamatelopoulos K, Brinker M, Schloemer P, Glasauer A, Solomon SD, Vaduganathan M

doi: 10.1001/jamacardio.2026.1365

Thrombosis and Stroke

Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial

JAMA Cardiol

Spiazzi BF, Brennan D, Zingano CP, Powell HA, Nicholls SJ, Nissen SE, Laffin LJ

doi: 10.1001/jamacardio.2026.1208

RECOMMENDED

Hypertension

Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

★ 3 Recommended by Prof. Dr Isabella Sudano, Faculty Member

Hypertension

Argeros Z, Xu X, Bhandari B, Harris K, Touyz RM, Schutte AE

doi: 10.1161/HYPERTENSIONAHA.125.25129

Heart, Artery and Coronary DiseasesTherapy and Intervention

Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial

JAMA Cardiol

Ternacle J, Hahn RT, Silva I, Alperi A, Giuliani C, Zanuttini A, Théron A, Dahou A, Cristell N, Woods T, Guzzetti E, Turgeon PY, Bernier M, Mahjoub H, Paquin A, Skaf S, Beaudoin J, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Leipsic J, Blanke P, Williams MR, McCabe JM, Brown DL, Babaliaros V, Goldman S, Szeto WY, Généreux P, Pershad A, Nazif TM, Zhang Y, Gunnarsson M, Webb JG, Makkar RR, Thourani VH, Mack MJ, Leon MB, Pibarot P, PARTNER 3 Investigators

doi: 10.1001/jamacardio.2026.2299

Cardiac Arrest or Death

Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trial

Am Heart J

Bloom JE, Ball J, Okyere D, Voskoboinik A, Dawson LP, Nelson AJ, Percival M, Meadley B, Salathiel R, McManamny T, Boggett S, Batchelor R, Hartshorne T, Palmer S, Reid C, Anderson D, Pilcher D, Chew DP, Kaye DM, Nehme Z, Stub D, PANDA Investigators

doi: 10.1016/j.ahj.2026.107378

Related content

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post Hoc Analysis of the FINEARTS-HF Randomized Clinical Trial

Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial

Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical Trials

Bempedoic Acid and Venous Thromboembolism Risk Among Statin-Intolerant Patients: A Post Hoc Analysis of the CLEAR Outcomes Randomized Clinical Trial

Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial

Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trial